CX546

CAS No. 215923-54-9

CX546( —— )

Catalog No. M20795 CAS No. 215923-54-9

CX546 is an AMPA receptor modulator. CX546 enhances cognitive function in rats. It has also been proposed as a treatment for schizophrenia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 32 In Stock
10MG 46 In Stock
25MG 92 In Stock
50MG 161 In Stock
100MG 243 In Stock
200MG 359 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CX546
  • Note
    Research use only, not for human use.
  • Brief Description
    CX546 is an AMPA receptor modulator. CX546 enhances cognitive function in rats. It has also been proposed as a treatment for schizophrenia.
  • Description
    CX546 is an AMPA receptor modulator. CX546 enhances cognitive function in rats. It has also been proposed as a treatment for schizophrenia.
  • In Vitro
    ——
  • In Vivo
    Treatment with the ampakine CX614 (intraperitoneal injection) markedly and reversibly increase brain-derived neurotrophic factor (BDNF) mRNA and protein levels in cultured rat entorhinal/hippocampal slices.
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    iGluR
  • Recptor
    AMPAR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    215923-54-9
  • Formula Weight
    247.29
  • Molecular Formula
    C14H17NO3
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol:100 mg/mL (404.38 mM; Need ultrasonic);H2O:2 mg/mL (8.09 mM; Need ultrasonic)
  • SMILES
    O=C(c1ccc2c(c1)OCCO2)N1CCCCC1
  • Chemical Name
    23-Dihydro-14-benzodioxin-7-yl-(1-piperidyl)methanone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nagarajan N Quast C Boxall A R et al. Mechanism and impact of allosteric AMPA receptor modulation by the AmpakineTM CX546[J]. Neuropharmacology 2001 41(6):0-663.
molnova catalog
related products
  • BPAM344

    BPAM344 is a potent positive allosteric modulator (PAM) of the KAR subunits GluK1b, GluK2a, and GluK3a.

  • SYM-2206

    An allosteric, non-competitive antagonist of the AMPA receptor with IC50 of 2.8 uM.

  • Rapastinel

    A tetrapeptide (TPPT-amide) that acts as a NMDA receptor glycine site partial agonist.